Gavi plans to use U.S. cash for malaria, while meeting Kennedy's conditions
By Jennifer Rigby LONDON, June 8 (Reuters) - The global vaccine group Gavi said on Monday it hopes to use $600 million in soon-to-be-restored U.S. funding to boost malaria and other vaccination efforts, as it also meets U.S. conditions over phasing out the preservative thimerosal in other vaccines 
